In order to strengthen international friendly exchanges, deepen economic, trade and investment cooperation, and implement the consensus reached by the leaders of China and the United States, the People’s Government of Guangdong Province successfully hosted the China (Guangdong)-U.S. (New York) Economic and Trade Cooperation and Exchange Conference in New York City, the United States, on May 13. Hu Chunhua, member of the Political Bureau of the CPC Central Committee and Secretary of the Guangdong Provincial Party Committee, attended and delivered a keynote speech on “Deepening Mutually Beneficial Cooperation to Create a Better Future.” Cui Tiankai, Chinese Ambassador to the United States, Xu Qin, Mayor of Shenzhen, Patrick Sandillo, Deputy Assistant Secretary of the U.S. Department of Commerce, New York State Lieutenant Governor Kathy Hocker, Bo Myron, Advisor to the Governor of Guangdong Province and Executive Vice President of the National Chamber of Commerce, and Zhang Qiyue, Consul General of the Chinese Consulate General in New York, were present.
This China (Guangdong)-U.S. (New York) Economic and Trade Cooperation and Exchange Conference covers world-renowned companies in high-tech fields such as medical and biotechnology, finance, and Internet+. Dr. Hu Xiang, Chairman of Beike Biotechnology, was invited to participate in this exchange event and delivered a keynote speech at the subsequent Sino-US Entrepreneurs Forum. 
China (Guangdong) – United States (New York) Economic and Trade Cooperation and Exchange Conference signing site (fourth from right Dr. Hu Xiang, chairman of Beike Biotechnology fifth from right Altor Dr. Huang Qingxiang of BioScience Company)
Under the general trend of economic globalization, this China (Guangdong)-US (New York) Economic and Trade Cooperation and Exchange Conference provides a broad platform for local cooperation between Guangdong and the United States, bringing more business opportunities to the two places. Beike Biosicence took this opportunity to enter into a comprehensive strategic cooperation with Altor Biosicence, a well-known American cancer treatment company, and join the “American Cancer Moonshot Plan”. The plan was announced during President Obama’s State of the Union address in January this year. The goal is to accelerate progress in the fight against cancer in the next five years and break down the boundaries that hinder researchers from collaborating. The plan is led by U.S. Vice President Biden, and is jointly launched by many of the world’s top U.S. biotech companies, including Altor Bioscience, Amgen and Celgene, U.S. oncology research institutions, the largest U.S. health insurance payer and Bank of America. The official launch of this plan marks the official arrival of the era of personalized cancer treatment.
Beike Biotechnology will continue to strengthen cooperation and exchanges with leading international biotechnology companies through “going out” and “bringing in”, further deepening innovation and internationalization capabilities, enhancing the international influence of the corporate brand, actively participating in global industrial competition, and rapidly moving towards becoming a world-class enterprise in the health field.